Article info
Uterine Cancer
Performance of Serum CA125 as a Prognostic Biomarker in Patients With Uterine Papillary Serous Carcinoma
- Address correspondence and reprint requests to Divya Gupta, MD, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Weill Cornell Medical College, 525 E 68th St, Suite J-130, New York, NY 10065. E-mail: dig2010{at}med.cornell.edu or Gloria Huang, MD, Division of Gynecologic Oncology, Department of Obstetrics & Gynecology and Women's Health, Albert Einstein College of Medicine/Montefiore Medical Center, 1695 Eastchester Road, Suite 601, Bronx, NY 10461. E-mail: gloria.huang{at}einstein.yu.edu.
Citation
Performance of Serum CA125 as a Prognostic Biomarker in Patients With Uterine Papillary Serous Carcinoma
Publication history
- Received October 28, 2010
- First published April 1, 2011.
Online issue publication
June 17, 2019
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright © 2011 by IGCS and ESGO